GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Issuance of Debt

Curocell (XKRX:372320) Issuance of Debt : ₩47,898.50 Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Issuance of Debt?

Curocell's Issuance of Debt for the six months ended in Jun. 2023 was ₩44,792.10 Mil.

Curocell's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2023 was ₩47,898.50 Mil.


Curocell Issuance of Debt Historical Data

The historical data trend for Curocell's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Issuance of Debt Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
- - 6,607.00 19,478.00 47,898.50

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Issuance of Debt 6,859.60 12,618.40 44,792.10 3,106.40

Curocell Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₩47,898.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curocell Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Curocell's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines